Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Value Of Sanofi Lies In Its Predictability
Seeking Alpha
Tuesday, October 29, 2013 - 9:32am
tags:
Sanofi
Pfizer 3Q net falls due to generics, higher costs
Yahoo/AP
Tuesday, October 29, 2013 - 9:30am
tags:
Pfizer, earnings
Recent FDA News Makes A Zalicus Trade Look Even More Compelling
Seeking Alpha
Tuesday, October 29, 2013 - 9:24am
tags:
FDA, Zalicus, Z160, Zohydro ER, Zogenix, painkillers
Why Gilead's Sofosbuvir Is Better Than J&J's Simeprevir
Motley Fool
Tuesday, October 29, 2013 - 9:21am
tags:
Gilead, sofosbuvir, JNJ, hepatitis C, simeprevir
Vertex to reduce workforce, focus on opportunities in Cystic Fibrosis, other R&D
The Fly on the Wall
Tuesday, October 29, 2013 - 9:18am
tags:
Vertex Pharmaceuticals, layoffs, cystic fibrosis
4 Healthcare Stock Stories Getting Noticed on Monday
Wall St. Cheat Sheet
Monday, October 28, 2013 - 7:46pm
tags:
Merck, Teva, Clovis Oncology, Illumina
Eli Lilly: Cymbalta Patent Expiry Quantified
Seeking Alpha
Monday, October 28, 2013 - 3:33pm
tags:
patents, Eli Lilly, Cymbalta, Pfizer, Merck, antidepressants
3 Takeaways You Need to Know From Merck's Earnings
Motley Fool
Monday, October 28, 2013 - 3:29pm
tags:
Merck, earnings, Januvia, Singulair, Gardasil
Earnings Preview: Pfizer's new drug sales will be critical in Q3 report
The Fly on the Wall
Monday, October 28, 2013 - 3:19pm
tags:
earnings, Pfizer
NeoStem: Catalysts Upcoming, Financing In Rear View Mirror
Seeking Alpha
Monday, October 28, 2013 - 3:18pm
tags:
NeoStem, AMR-101
Bristol-Myers Squibb Gains 6% on Promising Cancer Treatment, Upgrade
Barron's
Monday, October 28, 2013 - 12:10pm
tags:
Bristol-Myers Squibb, nivolumab, lung cancer
Is Glaxo Keeping Its Commitment To Releasing Paxil Trial Data?
Pharmalot
Monday, October 28, 2013 - 12:04pm
tags:
GSK, Paxil, clinical trial data
Dendreon Buyout? Don't Get Too Excited
Seeking Alpha
Monday, October 28, 2013 - 12:03pm
tags:
Dendreon, M&A
DARA Raises Cash, Expands Sales Force
Seeking Alpha
Monday, October 28, 2013 - 12:03pm
tags:
DARA Biosciences, Alamo Pharma Services, Soltamox, Gelcair, Bionect
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Monday, October 28, 2013 - 10:26am
tags:
patents, Copaxone, Teva, Nexium, AstraZeneca, Micardis, Boehringer Ingelheim, Sandostatin LAR, Novartis, Exforge, Nasonex, Merck, TriLipix, AbbVie, Evista, Eli Lilly, Restasis, Allergan, Renagel, Sanofi
3 Diagnostic Stocks That May See Sales Soar Because of Obamacare
Motley Fool
Monday, October 28, 2013 - 10:23am
tags:
Affordable Care Act, diagnostics, Intuitive Surgical, OraSure, Sequenom
Philips, Infraredx ink resale deal
Mass Device
Monday, October 28, 2013 - 10:22am
tags:
devices, Philips, InfraReDx, TVC imaging
The Questionable Dendreon Buyout Incentive
Yahoo/Wall St 24-7
Monday, October 28, 2013 - 9:57am
tags:
Dendreon, Provenge, M&A
Edwards Lifesciences earnings rise
Reuters
Monday, October 28, 2013 - 9:53am
tags:
Edwards Lifesciences, earnings
Time Is No Friend To Synta's Lung Cancer Drug
TheStreet.com
Monday, October 28, 2013 - 9:52am
tags:
Synta Pharmaceuticals, lung cancer, ganetespib

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.